Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Multi-talker background and semantic priming effect.

Frontiers in human neuroscience

Dekerle M, Boulenger V, Hoen M, Meunier F.
PMID: 25400572
Front Hum Neurosci. 2014 Oct 31;8:878. doi: 10.3389/fnhum.2014.00878. eCollection 2014.

The reported studies have aimed to investigate whether informational masking in a multi-talker background relies on semantic interference between the background and target using an adapted semantic priming paradigm. In 3 experiments, participants were required to perform a lexical...

Cite
Dekerle M, Boulenger V, Hoen M, et al. Multi-talker background and semantic priming effect. Front Hum Neurosci. 2014;8:878doi: 10.3389/fnhum.2014.00878.
Dekerle, M., Boulenger, V., Hoen, M., & Meunier, F. (2014). Multi-talker background and semantic priming effect. Frontiers in human neuroscience, 8878. https://doi.org/10.3389/fnhum.2014.00878
Dekerle, Marie, et al. "Multi-talker background and semantic priming effect." Frontiers in human neuroscience vol. 8 (2014): 878. doi: https://doi.org/10.3389/fnhum.2014.00878
Dekerle M, Boulenger V, Hoen M, Meunier F. Multi-talker background and semantic priming effect. Front Hum Neurosci. 2014 Oct 31;8:878. doi: 10.3389/fnhum.2014.00878. eCollection 2014. PMID: 25400572; PMCID: PMC4215827.
Copy Download .nbib Format: NLM
Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Guzik P, Fang HY, Deberle LM, Benešová M, Cohrs S, Boss SD, Ametamey SM, Schibli R, Müller C.
PMID: 33452043
J Nucl Med. 2021 Oct;62(10):1475-1481. doi: 10.2967/jnumed.120.255760. Epub 2021 Jan 15.

The aim of this study was to identify a folate receptor-α (FRα)-selective PET agent potentially suitable for the selection of patients who might profit from FRα-targeted therapies. The 6

Cite
Guzik P, Fang HY, Deberle LM, et al. Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. J Nucl Med. 2021;62(10):1475-1481doi: 10.2967/jnumed.120.255760.
Guzik, P., Fang, H. Y., Deberle, L. M., Benešová, M., Cohrs, S., Boss, S. D., Ametamey, S. M., Schibli, R., & Müller, C. (2021). Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(10), 1475-1481. https://doi.org/10.2967/jnumed.120.255760
Guzik, Patrycja, et al. "Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,10 (2021): 1475-1481. doi: https://doi.org/10.2967/jnumed.120.255760
Guzik P, Fang HY, Deberle LM, Benešová M, Cohrs S, Boss SD, Ametamey SM, Schibli R, Müller C. Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. J Nucl Med. 2021 Oct;62(10):1475-1481. doi: 10.2967/jnumed.120.255760. Epub 2021 Jan 15. PMID: 33452043.
Copy Download .nbib Format: NLM
Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics.

Bioconjugate chemistry

Deberle LM, Benešová M, Becker AE, Ratz M, Guzik P, Schibli R, Müller C.
PMID: 34251183
Bioconjug Chem. 2021 Aug 18;32(8):1617-1628. doi: 10.1021/acs.bioconjchem.1c00198. Epub 2021 Jul 12.

The folate receptor (FR) is an interesting target for radiotheranostics due to its overexpression in several tumor types. The progress in developing novel folate radioconjugates is, however, slow due to the synthetic challenges that folate chemistry presents. The goal...

Cite
Deberle LM, Benešová M, Becker AE, et al. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. Bioconjug Chem. 2021;32(8):1617-1628doi: 10.1021/acs.bioconjchem.1c00198.
Deberle, L. M., Benešová, M., Becker, A. E., Ratz, M., Guzik, P., Schibli, R., & Müller, C. (2021). Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. Bioconjugate chemistry, 32(8), 1617-1628. https://doi.org/10.1021/acs.bioconjchem.1c00198
Deberle, Luisa M, et al. "Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics." Bioconjugate chemistry vol. 32,8 (2021): 1617-1628. doi: https://doi.org/10.1021/acs.bioconjchem.1c00198
Deberle LM, Benešová M, Becker AE, Ratz M, Guzik P, Schibli R, Müller C. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. Bioconjug Chem. 2021 Aug 18;32(8):1617-1628. doi: 10.1021/acs.bioconjchem.1c00198. Epub 2021 Jul 12. PMID: 34251183.
Copy Download .nbib Format: NLM
The authors reply.

Critical care medicine

DeMerle KM, Seymour CW.
PMID: 34529626
Crit Care Med. 2021 Oct 01;49(10):e1048. doi: 10.1097/CCM.0000000000005115.

No abstract available.

Cite
DeMerle KM, Seymour CW. The authors reply. Crit Care Med. 2021;49(10):e1048doi: 10.1097/CCM.0000000000005115.
DeMerle, K. M., & Seymour, C. W. (2021). The authors reply. Critical care medicine, 49(10), e1048. https://doi.org/10.1097/CCM.0000000000005115
DeMerle, Kimberley M, and Seymour, Christopher W. "The authors reply." Critical care medicine vol. 49,10 (2021): e1048. doi: https://doi.org/10.1097/CCM.0000000000005115
DeMerle KM, Seymour CW. The authors reply. Crit Care Med. 2021 Oct 01;49(10):e1048. doi: 10.1097/CCM.0000000000005115. PMID: 34529626; PMCID: PMC8488862.
Copy Download .nbib Format: NLM
Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Guzik P, Fang HY, Deberle LM, Benešová M, Cohrs S, Boss SD, Ametamey SM, Schibli R, Müller C.
PMID: 33452043
J Nucl Med. 2021 Oct;62(10):1475-1481. doi: 10.2967/jnumed.120.255760. Epub 2021 Jan 15.

The aim of this study was to identify a folate receptor-α (FRα)-selective PET agent potentially suitable for the selection of patients who might profit from FRα-targeted therapies. The 6

Cite
Guzik P, Fang HY, Deberle LM, et al. Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. J Nucl Med. 2021;62(10):1475-1481doi: 10.2967/jnumed.120.255760.
Guzik, P., Fang, H. Y., Deberle, L. M., Benešová, M., Cohrs, S., Boss, S. D., Ametamey, S. M., Schibli, R., & Müller, C. (2021). Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(10), 1475-1481. https://doi.org/10.2967/jnumed.120.255760
Guzik, Patrycja, et al. "Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,10 (2021): 1475-1481. doi: https://doi.org/10.2967/jnumed.120.255760
Guzik P, Fang HY, Deberle LM, Benešová M, Cohrs S, Boss SD, Ametamey SM, Schibli R, Müller C. Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy. J Nucl Med. 2021 Oct;62(10):1475-1481. doi: 10.2967/jnumed.120.255760. Epub 2021 Jan 15. PMID: 33452043.
Copy Download .nbib Format: NLM
A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions.

Innovations in clinical neuroscience

Spiegel DR, Mccroskey AL, Deyerle BA.
PMID: 27354927
Innov Clin Neurosci. 2016 Apr 01;13(3):32-41. eCollection 2016.

Transient global amnesia is a clinical syndrome characterized by the sudden onset of anterograde amnesia, accompanied by repetitive questioning, sometimes with a retrograde component, lasting up to 24 hours, without compromise of other neurologic function. Neuroimaging after an acutetransient...

Cite
Spiegel DR, Mccroskey AL, Deyerle BA. A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions. Innov Clin Neurosci. 2016;13(3):32-41
Spiegel, D. R., Mccroskey, A. L., & Deyerle, B. A. (2016). A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions. Innovations in clinical neuroscience, 13(3), 32-41.
Spiegel, David R, et al. "A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions." Innovations in clinical neuroscience vol. 13,3 (2016): 32-41.
Spiegel DR, Mccroskey AL, Deyerle BA. A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions. Innov Clin Neurosci. 2016 Apr 01;13(3):32-41. eCollection 2016. PMID: 27354927; PMCID: PMC4911939.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries